Scheele J, Stangl R, Altendorf-Hofmann A
Department of Surgery, University Hospital, Erlangen, FRG.
Br J Surg. 1990 Nov;77(11):1241-6. doi: 10.1002/bjs.1800771115.
From 1960 to 1987, 1209 patients with colorectal liver metastases were recorded, and followed until 1 January 1990. In 242 cases the diagnosis was based on external imaging, whereas 967 patients had operative confirmation and staging of their liver disease. Three groups of patients were analysed: group 1 involved 921 cases, of whom 902 were deemed non-resectable whereas 19 could not be unequivocally classified. Only 21 patients lived for longer than 3 years, seven survived for 4 years, but there were no 5-year survivors. Group 2 comprised 62 highly selected patients who at laparotomy demonstrated resectable metastatic spread confined to the liver, but this was not treated mainly because of a formerly different therapeutic approach. These patients had a significantly longer median survival time (14.2 versus 6.9 months), but also failed to achieve 5-year survival. The 226 patients forming group 3 underwent hepatic resection with intent to cure. Nine of them had minimal macroscopic disease left, and 34 with all gross tumour removed had positive margins. Survival of patients with these 43 eventually non-radical resections followed an identical course as in group 2 (median survival 13.3 months, maximum 42 months). Of the 183 patients with potentially curative resection ten died after surgery (5.5 per cent). Actuarial 5 and 10-year survival rates in the remaining 173 patients were 40 and 27 per cent with 25 and seven patients alive at respective periods of time. Until 1 January 1990, 64 patients remained free from recurrent disease for up to 24 years. In three patients the tumour status at death was unclear. The other 106 patients developed definite cancer relapse. Nevertheless they demonstrated a prolongation of survival time by a median of 1 year when compared with the 43 non-radically resected patients or the 62 untreated patients with resectable liver-only metastases, and accomplished a maximum survival time of 8 years. Radical excision of colorectal secondaries to the liver therefore offers effective palliation, and in a small number the chance of a cure.
1960年至1987年期间,共记录了1209例结直肠癌肝转移患者,并随访至1990年1月1日。其中242例的诊断基于外部影像学检查,而967例患者通过手术确诊并对其肝脏疾病进行了分期。对三组患者进行了分析:第一组有921例,其中902例被认为无法切除,19例无法明确分类。只有21例患者存活超过3年,7例存活4年,但无一例存活5年。第二组包括62例经过严格筛选的患者,他们在剖腹手术中显示可切除的转移灶局限于肝脏,但主要由于之前不同的治疗方法而未进行治疗。这些患者的中位生存时间显著更长(14.2个月对6.9个月),但也未实现5年生存。组成第三组的226例患者接受了旨在治愈的肝切除术。其中9例术后残留微小肉眼可见病灶,34例所有大体肿瘤均被切除但切缘阳性。这43例最终未行根治性切除的患者的生存情况与第二组相同(中位生存13.3个月,最长42个月)。183例可能治愈性切除的患者中有10例术后死亡(5.5%)。其余173例患者的精算5年和10年生存率分别为40%和27%,相应时间点分别有25例和7例患者存活。截至1990年1月1日,64例患者无疾病复发长达24年。3例患者死亡时的肿瘤状态不明。其他106例患者出现了明确的癌症复发。然而,与43例未行根治性切除的患者或62例未治疗的仅肝转移可切除患者相比,他们的生存时间中位数延长了1年,最长生存时间为8年。因此,对结直肠癌肝转移灶进行根治性切除可提供有效的姑息治疗,少数患者还有治愈的机会。